Skip to main content

ORIGINAL RESEARCH article

Front. Pharmacol.
Sec. Renal Pharmacology
Volume 16 - 2025 | doi: 10.3389/fphar.2025.1522285

Synergistic Effects of 6-Shogaol and Hyperthermia on ACHN Renal Cancer Cells: Modulation of ROS and Heat Shock Pro-teins in Cancer Therapy

Provisionally accepted
  • College of Korean Medicine, Dongguk University, Gyeongju, Gyeonggi, Republic of Korea

The final, formatted version of the article will be published soon.

    Introduction: Renal cancer is known for its aggressive progression and resistance to standard treatments, underscoring the need for novel therapeutic strategies. This study explores the potential of combining 6-shogaol (6-SHO), a bioactive compound derived from ginger (Zingiber officinale), with hyperthermia to enhance anticancer efficacy in ACHN renal cancer cells.Methods: ACHN cells were treated with 6-SHO and exposed to hyperthermic conditions. We evaluated the combined effects on apoptosis, cell cycle arrest, and cell proliferation, as well as the role of reactive oxygen species (ROS) and heat shock proteins (HSPs) in mediating these responses.Results: The combination of 6-SHO and hyperthermia significantly increased apoptosis, induced G2/M phase cell cycle arrest, and reduced cell proliferation more effectively than either treatment alone. ROS played a critical role in these effects, with modulation of HSPs and heat shock factor 1 (HSF1) further disrupting cancer cell survival mechanisms.Discussion: These findings highlight the synergistic potential of 6-SHO and hyperthermia as a novel therapeutic approach in renal cancer treatment, supporting the need for further research and clinical evaluation.

    Keywords: 6-Shogaol, hyperthermia, renal cancer, Apoptosis, cell cycle arrest, reactive oxygen species (ROS), Heat shock proteins (HSPs), combination treatment

    Received: 04 Nov 2024; Accepted: 31 Jan 2025.

    Copyright: © 2025 Ahn and Baek. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Seung Ho Baek, College of Korean Medicine, Dongguk University, Gyeongju, Gyeonggi, Republic of Korea

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.